CHICAGO (Reuters) - Aiming powerful beams of radiation precisely at tumors helped control their growth and helped people with early stage but inoperable lung cancer live longer, U.S. researchers said on Tuesday. They said intensive radiation therapy -- done in one to five treatments instead of the conventional 20 to 30 -- provided more than double the rate of primary tumor control ...

Despite huge strides in treatment over the past four decades, cancer remains the second leading cause of death in the United States, claiming the lives of 560,000 people last year, a report said Tuesday. The report in a special edition of the Journal of the American Medical Association (JAMA) said the work of doctors and scientists has slashed the ...

US doctors and scientists have made huge strides in the fight against cancer in the past four decades, slashing the death rate by nearly 16 percent, a report published Tuesday showed. But cancer remained the second leading cause of death in the United States last year, striking 1.5 million people and claiming the lives of 560,000 of them ...

BioSante Pharmaceuticals has received orphan drug status for its potential pancreatic cancer treatment, the company said Monday. The company said the Food and Drug Administration designation applied to its GVAX Pancreas Vaccine, which is undergoing clinical trials with other anticancer agents for safety, survival and response rates. The GVAX Pancreas Vaccine ...